D002248Chemicals & DrugsD01.200.250D01.362.200D01.650.550.250450.995428Carbon MonoxideFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentDivisionvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson19798693Liptay MJ, Basu S, Hoaglin MC, Freedman N, Faber LP, Warren WH, Hammoud ZT, Kim AWJournal of surgical oncologyDiffusion lung capacity for carbon monoxide (DLCO) is an independent prognostic factor for long-term survival after curative lung resection for cancer. J Surg Oncol. 2009 Dec 15; 100(8):703-7.J Surg Oncol2009-12-15T00:00:002009Diffusion lung capacity for carbon monoxide (DLCO) is an independent prognostic factor for long-term survival after curative lung resection for cancer.KalipadaPahanKalipada Pahan349039Pahan, KalipadaProfessor8543053Pahan K, Khan M, Smith BT, Singh IFEBS lettersKetoconazole and other imidazole derivatives are potent inhibitors of peroxisomal phytanic acid alpha-oxidation. FEBS Lett. 1995 Dec 18; 377(2):213-6.FEBS Lett1995-12-18T00:00:001995Ketoconazole and other imidazole derivatives are potent inhibitors of peroxisomal phytanic acid alpha-oxidation.Rush University, College of Health SciencesEllenBeckerEllen Becker349174Becker, EllenProfessorChristopherSederChristopher Seder349647Seder, ChristopherAssistant Professor6Assistant Professor4Professor20130351Busl KM, Greer DMNeuroRehabilitationHypoxic-ischemic brain injury: pathophysiology, neuropathology and mechanisms. NeuroRehabilitation. 2010; 26(1):5-13.NeuroRehabilitation2010-01-01T00:00:002010Hypoxic-ischemic brain injury: pathophysiology, neuropathology and mechanisms.0.4253160.03505434research area of0.3715590.03521535subject area forNeurological SciencesRush University, Rush Medical CollegeMichaelLiptayMichael Liptay41.87340050000000-87.67011710000000349003Liptay, MichaelProfessorCardiopulmonary SciencesCardiovascular and Thoracic Surgerytrue1ProfessorProfessortrue1ProfessorProfessortrue1Assistant ProfessorAssistant Professor37193597Becker EA, Moran EM, Blonshine JB, Blonshine SBRespiratory careDLCO Biologic Quality-Control Findings From a Multi-Center Global Study. Respir Care. 2023 09; 68(9):1245-1253.Respir Care2023-05-16T00:00:002023DLCO Biologic Quality-Control Findings From a Multi-Center Global Study.35921862Karush JM, Alex G, Geissen N, Wakefield C, Basu S, Liptay MJ, Seder CWThe Annals of thoracic surgeryPredicting Non-home Discharge After Lung Surgery: Analysis of the General Thoracic Surgery Database. Ann Thorac Surg. 2023 03; 115(3):687-692.Ann Thorac Surg2022-07-31T00:00:002022Predicting Non-home Discharge After Lung Surgery: Analysis of the General Thoracic Surgery Database.true1ProfessorProfessor